RXRA and cardiac hypertrophy: Among them, five signaling pathways, such as PPAR and PPARα/RXRα activation, were significantly downregulated, and the cardiac hypertrophy signaling, pulmonary fibrosis idiopathic signaling pathway, and S100 family signaling pathway were significantly upregulated (Table S6, Figure 5b).